医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Gemtech Targets the Asian Market with Its Medical Devices and Coating and Plating, and Special Spray Products

2019年07月16日 AM10:00
このエントリーをはてなブックマークに追加


 

CHANGWON, South Korea

Gemtech Co., Ltd. is enhancing its R&D and marketing capability to expand the business into the Asian market with its medical devices, coating and plating facility, and special spray products.

Gemtech is focused on designing and manufacturing high-quality products from medical devices including low-frequency therapeutic units, therapeutic ultrasound units, phototherapy units, and devices for rehabilitation; electrophoretic, particulate, and shot coating facilities; to ceramic, lubricating, and Teflon coating systems.

Gemtech’s flagship products include Tea Tree 10 Spotcare made of tea tree oil, cotton swab lip tint and remover, GT-K100 massage machine for gonarthritis, small-sized low-frequency stimulator PULSE EGG SR-50, TENS menstrual pain reliever, and high-frequency thermography unit SIRIUS.

Founded in January 1996, Gemtech established its own research institute and selected as one of the promising small and medium enterprises. Under the management philosophy of “we produce the best quality products, keeping in mind that our family members use the product we produced,” the company is focused on achieving goals including 100 percent customer approval rating, zero defection, building the best quality assurance system, and globalizing its brand. Approved by FDA and certified according to ISO 14001, the company’s various products are known for excellent technology and exported to Japan. Currently, Gemtech is committed to expanding its business into the global market.

Gemtech Technology Institute is accelerating its R&D to boost human health by improving the quality of life through new technology and products in the medical device industry.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190715005840/en/

CONTACT

Gemtech Co., Ltd.

Cho Hong Sig

+82-55-237-5533

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease